Showing results (21-30 of 95) with videos related to
Sort By:
Pageof 10
Endocrine|April 30, 2013
Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertilityDimitrios Panidis, Konstantinos Tziomalos, Efstathios Papadakis, et al.The Journal of Reproductive Medicine|July 3, 2002
Round-headed spermatozoa in semen specimens from fertile and subfertile menJohn Kalahanis, David Rousso, Anargyros Kourtis, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 24, 2005
Receiver operator characteristics and diagnostic value of progesterone and CA-125 in the prediction of ectopic and abortive intrauterine gestationsIlias Katsikis, David Rousso, Dimitrios Farmakiotis, et al.European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 1, 2011
Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndromeIlias Katsikis, Artemis Karkanaki, Georgios Misichronis, et al.Hormones (Athens, Greece)|January 3, 2015
The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markersCharikleia Christakou, Anastasios Kollias, Christina Piperi, et al.European Journal of Endocrinology|August 3, 2005
Resistin levels in hyperthyroid patients before and after restoration of thyroid function: relationship with body weight and body compositionGerasimos E Krassas, Nikolaos Pontikides, Kostas Loustis, et al.Human Reproduction (Oxford, England)|January 15, 2013
Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndromeKonstantinos Tziomalos, Ilias Katsikis, Efstathios Papadakis, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|December 11, 2012
Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndromeEkaterini Koiou, Konstantinos Tziomalos, Ilias Katsikis, et al.Fertility and Sterility|August 9, 2005
Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndromeDimitrios Panidis, Dimitrios Farmakiotis, David Rousso, et al.Hormones (Athens, Greece)|January 25, 2014
Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndromeEkaterini Koiou, Konstantinos Tziomalos, Ilias Katsikis, et al.Pageof 10